• This email address is being protected from spambots. You need JavaScript enabled to view it.
Aurum Ghana - TB Reach Application Selected For Funding

Aurum Ghana - TB Reach Application Selected For Funding

Congratulations to the Aurum Ghana team! The "TB REACH Wave 6" application, 1109: Engaging private health providers & National Health Insurance to scale up active TB case finding among vulnerable populations, was part of 42 applications, selected out of over 570, for funding.

The first fully bilateral funding in Ghana is for $978,000 over 18 months.

ABOUT TB REACH:

Almost nine million people around the world become ill with tuberculosis (TB) each year. More than one-third of them fail to gain access to accurate diagnosis or effective treatment and are suffering and dying needlessly from this curable disease. Many of these people live in poverty-stricken areas and have very limited or non-existent access to health services.

Additionally, the failure to detect so many infectious TB cases is thwarting our efforts to reduce the spread of TB and eliminate it. This problem cannot be solved by any single organization or country.

The main objective of TB REACH is to increase case detection of TB, detect the disease as early as possible, and ensure timely and complete treatment while maintaining high TB cure rates. TB REACH focuses on reaching people with limited or no access to TB services and looking for innovative ways to do this.

Governments and civil society must strive jointly to introduce and implement innovative and ground-breaking techniques, interventions, approaches and activities that result in detecting the undetected TB cases, leading to a reduced rate of transmissions and preventing the emergence of drug-resistant forms of TB.

Through a wave based funding, TB REACH awards grants up to US $1,000,000 for a one year period to selected institutions or organizations that have put forward successful proposals in a timely fashion in order to detect additional TB cases.


© 2024 The Aurum Institute. All Rights Reserved.